SE384211B - Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner - Google Patents

Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner

Info

Publication number
SE384211B
SE384211B SE7105610A SE561071A SE384211B SE 384211 B SE384211 B SE 384211B SE 7105610 A SE7105610 A SE 7105610A SE 561071 A SE561071 A SE 561071A SE 384211 B SE384211 B SE 384211B
Authority
SE
Sweden
Prior art keywords
trialcoxikinazolines
amino
substituted
procedure
preparation
Prior art date
Application number
SE7105610A
Other languages
English (en)
Swedish (sv)
Inventor
H-J E Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE384211B publication Critical patent/SE384211B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7105610A 1970-05-21 1971-04-29 Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner SE384211B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3954170A 1970-05-21 1970-05-21
US24086572A 1972-04-03 1972-04-03

Publications (1)

Publication Number Publication Date
SE384211B true SE384211B (sv) 1976-04-26

Family

ID=26716233

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7105610A SE384211B (sv) 1970-05-21 1971-04-29 Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE7314685A SE400280B (sv) 1970-05-21 1973-10-29 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7314685A SE400280B (sv) 1970-05-21 1973-10-29 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner

Country Status (10)

Country Link
US (2) US3669968A (nl)
JP (1) JPS5268191A (nl)
AT (1) AT308120B (nl)
BE (1) BE766444A (nl)
CH (1) CH521353A (nl)
DE (2) DE2120495C2 (nl)
FR (1) FR2092154B1 (nl)
GB (1) GB1309835A (nl)
NL (1) NL178594C (nl)
SE (2) SE384211B (nl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980650A (en) * 1972-05-05 1976-09-14 N.V. Koninklijke Pharmaceutische Fabrieken V/H Brocades-Stheeman En Pharmacia 4-Amino-pyrimidine derivatives
GB1383409A (en) * 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
JPS536156B2 (nl) * 1972-10-30 1978-03-04
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4060615A (en) * 1976-02-18 1977-11-29 Mead Johnson & Company 2-Piperazinyl-6,7-dimethoxyquinazolines
DK140695C (da) 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf
SE435380B (sv) 1976-06-15 1984-09-24 Pfizer Forfarande for framstellning av kinazolinforeningar
US4101548A (en) * 1977-02-22 1978-07-18 Bristol-Myers Company 1,2,3-Thiadiazole amides
US4171363A (en) * 1977-02-22 1979-10-16 Bristol-Myers Company 1,2,3-Thiadiazole process
US4102885A (en) * 1977-06-20 1978-07-25 Bristol-Myers Company Process for preparing 2,4-dihaloquinazolines
US4098788A (en) * 1977-06-20 1978-07-04 Bristol-Myers Company Process for preparing quinazolines
US4130647A (en) * 1977-07-08 1978-12-19 Pfizer Inc. Methods for treating congestive heart failure and ischemic heart disease
DK154082C (da) * 1977-11-05 1989-02-27 Pfizer Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US4377581A (en) * 1980-03-03 1983-03-22 Pfizer Inc. Chloro- and alkoxy-substituted-2,4-diaminoquinazolines
US4351940A (en) * 1980-03-03 1982-09-28 Pfizer Inc. Chloro- and alkoxy-substituted-2-chloro-4-aminodquinazolines
US4510307A (en) * 1980-08-20 1985-04-09 Asahi Kasei Kogyo Kabushiki Kaisha 6-Quinazolinesulfonyl derivatives and process for preparation thereof
FI70411C (fi) 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4582832A (en) * 1984-10-09 1986-04-15 Pfizer Inc. Trimazosin as an anti-atherosclerosis agent
GB8910722D0 (en) * 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US5859070A (en) * 1993-10-18 1999-01-12 Imperial Chemical Industries, Plc Catalytic process
MXPA03002410A (es) * 2000-09-20 2003-06-19 Merck Patent Gmbh 4-amino-quinazolinas.
ES2362998T3 (es) 2002-08-19 2011-07-18 Pfizer Inc. Terapia de combinación para enfermedades hiperproliferativas.
EP1571146A4 (en) * 2002-12-10 2010-09-01 Ono Pharmaceutical Co NITROGENIC HETEROCYCLIC COMPOUNDS AND THEIR MEDICAL USE
GEP20084406B (en) * 2003-05-30 2008-06-25 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
CA2573103A1 (en) * 2004-07-06 2006-02-09 Angion Biomedica Corporation Quinazoline modulators of hepatocyte growth factor / c-met activity for the treatment of cancer
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US20070213319A1 (en) * 2006-01-11 2007-09-13 Angion Biomedica Corporation Modulators of hepatocyte growth factor/c-Met activity
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
CN101494980A (zh) * 2006-07-14 2009-07-29 兰贝克赛实验室有限公司 HMG-CoA还原酶抑制剂的多晶型形式及其应用
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives

Also Published As

Publication number Publication date
JPS5268191A (en) 1977-06-06
AT308120B (de) 1973-06-25
US3769286A (en) 1973-10-30
NL7106029A (nl) 1971-11-23
GB1309835A (en) 1973-03-14
FR2092154A1 (nl) 1972-01-21
JPS5439386B2 (nl) 1979-11-27
DE2167157C2 (de) 1982-06-09
DE2120495A1 (de) 1971-12-02
US3669968A (en) 1972-06-13
FR2092154B1 (nl) 1975-01-17
NL178594C (nl) 1986-04-16
BE766444A (fr) 1971-10-29
NL178594B (nl) 1985-11-18
CH521353A (fr) 1972-04-15
SE400280B (sv) 1978-03-20
DE2120495C2 (de) 1982-06-03

Similar Documents

Publication Publication Date Title
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE384368B (sv) Forfarande for framstellning av 6-substituerade - 4 - amino- 1,2 - dihydro - 1 - hydroxi - 2 - iminopyrimidiner
SE409708B (sv) Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidiner
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE7409801L (sv) Forfarande for framstellning av kinolinforeningar.
NO138883C (no) Fremgangsmaate for fremstilling av oksiranforbindelser
RO71354A (ro) Procedeu pentru prepararea unor p-halofenil-2-pirolidinone
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE385011B (sv) Forfarande for framstellning av alfa-linkosaminider
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE389105B (sv) Forfarande for framstellning av vissa angivna ketaziner
SE7505279L (sv) Forfarande for framstellning av hydroxipyrimidiner.
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
SE388611B (sv) Analogiforfarande for framstellning av 1,4-bensodiazeponderivat
SE406587B (sv) Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin
SE395699B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
SE380795B (sv) Forfarande for framstellning av tiokarbamider
SE398753B (sv) Forfarande for framstellning av 3',4'-didesoxitanamycin b
SE411759B (sv) Forfarande for framstellning av erytromycyliminforeningar
SE389333B (sv) Forfarande for framstellning av ackalipolyfosfatkomplex av x-6-desoxi-5-hydroxitetsacyklin.
SE382046B (sv) Forfarande for framstellning av 1-aryloxi-2-propanol